Ovarian Cancer Clinical Trials


Writing About Experiences With Ovarian Cancer

This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovarian cancer. Investigators are also intere...

Learn More

DOD Long-Term Survivors of Ovarian Cancer (LTSOC)

: Stages III and IV serum ovarian cancer are the most lethal of all gynecologic cancers; however, some advanced-stage ovarian cancer patients are long-term survivors. These patients may provide the key to long-term surviva...

Learn More

Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer

The goal of this research study is to learn more about how women feel about an ovarian cancer screening program that involves getting a blood test to measure CA 125 levels. This includes finding out about women's quality of life and ...

Learn More

Long Term Survivors in Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Other: Retrospective, cross-sectional descriptive analysis
Sponsor:   University Medical Center Groningen
Recruiting - verified April 2017

Learn More

Writing About Experiences With Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Behavioral: Writing about ovarian cancer
Sponsor:   University of Maryland
Recruiting - verified May 2016

Learn More

Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Condition:   Ovarian Cancer
Interventions:   Behavioral: Questionnaire;   Behavioral: Interview
Sponsors:   M.D. Anderson Cancer Center;   United States Department of Defense
Active, not recruiting - verified March 2017

Learn More

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Other: PET/CT(3hours]
Sponsor:   Odense University Hospital
Recruiting - verified October 2016

Learn More

First Line Ovarian Cancer Treatment - Cohort Study

Condition:   Epithelial Ovarian Cancer
Intervention:   Drug: Bevacizumab
Sponsors:   ARCAGY/ GINECO GROUP;   Roche Pharma AG
Completed - verified March 2016

Learn More

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Condition:   Ovarian Cancer
Interventions:   Drug: Veliparib;   Drug: Topotecan
Sponsors:   Vejle Hospital;   Abbott
Completed - verified June 2015

Learn More

Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Drug: Carboplatin and / or taxol chemotherapy
Sponsor:   Rennes University Hospital
Withdrawn - verified August 2014

Learn More

Hypodontia and Ovarian Cancer

Conditions:   Ovarian Cancer;   Hypodontia;   Breast Cancer;   Colon Cancer
Intervention:  
Sponsors:   University of Aarhus;   Danish Cancer Society;   Arvid-Nilsson Foundation
Unknown status - verified October 2013

Learn More

Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Procedure: ovarian cancer surgery
Sponsor:   Institut Cancerologie de l'Ouest
Recruiting - verified August 2016

Learn More

Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:  
Sponsor:   University of Virginia
Unknown status - verified December 2014

Learn More

Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study

Condition:   Ovarian Cancer
Intervention:   Procedure: DCE-MRI scans
Sponsor:   Memorial Sloan Kettering Cancer Center
Completed - verified October 2013

Learn More

Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer

Condition:   Ovarian Cancer
Interventions:   Genetic: protein expression analysis;   Other: immunohistochemistry
Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
Completed - verified April 2013

Learn More

Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Drug: Bendamustine HCL
Sponsors:   University of Arizona;   Cephalon
Completed - verified December 2015

Learn More

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Drug: Paclitaxel, Carboplatin and Vorinostat
Sponsors:   Herlev Hospital;   Odense University Hospital
Unknown status - verified October 2008

Learn More

NYU Ovarian Cancer Early Detection Program Blood and Genetics

Condition:   Ovarian Cancer
Intervention:  
Sponsor:   New York University School of Medicine
Terminated - verified January 2011

Learn More

Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function

Condition:   Ovarian Cancer
Intervention:   Behavioral: Fertility-Sparing Survey
Sponsors:   Dana-Farber Cancer Institute;   Beth Israel Deaconess Medical Center;   Brigham and Women's Hospital;   Massachusetts General Hospital
Completed - verified November 2016

Learn More

Elizabeth Registry for Low Grade Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Behavioral: Questionnaire
Sponsor:   M.D. Anderson Cancer Center
Completed - verified October 2015

Learn More

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Condition:   Ovarian Cancer
Intervention:   Drug: Topotecan
Sponsor:   Weill Medical College of Cornell University
Terminated - verified September 2006

Learn More

Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer

Condition:   Ovarian Cancer
Interventions:   Drug: Imatinib Mesylate;   Drug: Docetaxel
Sponsors:   Daniela Matei, MD;   Novartis Pharmaceuticals;   Sanofi;   Walther Cancer Institute
Completed - verified February 2016

Learn More

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Conditions:   Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions:   Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
Sponsors:   Northwestern University;   National Cancer Institute (NCI)
Recruiting - verified September 2016

Learn More

Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling

Condition:   Breast Cancer
Intervention:   Behavioral: Self Affirmation
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified July 14, 2017

Learn More

Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusions or Non-fusion NTRK Cancers

Conditions:   Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Breast Ductal Carcinoma NOS;   Melanoma;   Solid Tumors Cancer of Unknown Primary;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma;   Pancreatic Neoplasms;   Ovarian Neoplasms;   Carcinoma, Renal Cell;   Cholangiocarcinoma;   Skin Carcinoma;   Carcinoma, Bronchogenic;   Bronchial Neoplasms;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms, Nerve Tissue;   Nevi and Melanomas;   Intestinal Neoplasms;   Thyroid Cancer;   GIST;   Malignant Peripheral Nerve Sheath Tumors;   Breast Secretory Carcinoma;   Uterine Neoplasms
Intervention:   Drug: LOXO-195
Sponsor:   Loxo Oncology, Inc.
Recruiting - verified July 2017

Learn More

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

Conditions:   Cancer of Ovary;   Neoplasms, Ovarian;   Ovarian Cancer Stage IV;   Ovarian Cancer Recurrent;   Ovarian Cancer Stage III;   Ovary Cancer
Interventions:   Biological: Oregovomab;   Drug: Poly ICLC
Sponsor:   OncoQuest Inc.
Recruiting - verified July 2017

Learn More

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Conditions:   Solid Tumor, Adult;   Breast Cancer;   Non Small Cell Lung Cancer;   Prostate Cancer;   Ovarian Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Cholangiocarcinoma
Intervention:   Drug: CX-2009
Sponsor:   CytomX Therapeutics
Recruiting - verified July 2017

Learn More

A Study of SC?004 in Subjects With Advanced Solid Tumors

Condition:   Advanced Solid Tumor Cancers
Intervention:   Drug: SC-004
Sponsor:   AbbVie
Recruiting - verified July 2017

Learn More

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Conditions:   Advanced Malignancies;   Metastatic Malignancies
Interventions:   Drug: INCAGN01876;   Drug: Nivolumab;   Drug: Ipilimumab
Sponsor:   Incyte Biosciences International Sàrl
Recruiting - verified July 2017

Learn More

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Condition:   Advanced or Metastatic Solid Tumors
Interventions:   Drug: ABBV-368;   Drug: Nivolumab
Sponsor:   AbbVie
Recruiting - verified July 2017

Learn More

1-30 of 69
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.